ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

EMBO Journal

Volumn 16, Issue 7, 1997, Pages 1647-1655

  Graus Porta, Diana ^a   Beerli, Roger R ^a   Daly, John M ^a   Hynes, Nancy E ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

ErbB receptors; Lateral signaling; Receptor dimerization; Signal transduction; Single chain antibody

Indexed keywords

ANTIBODY; CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN; NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE;

ARTICLE; CELL LINE; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DIMERIZATION; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FEMALE; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MODELS, BIOLOGICAL; MODELS, STRUCTURAL; NEUREGULINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; VULVAR NEOPLASMS;

EID: 0030944455     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.7.1647     Document Type: Article

References (58)

1. Alimandi,M., Romano,A., Curia,M.C., Muraro,R., Fedi,P., Aaronson, S.A., Di Fiore,P.P. and Kraus,M.H. (1995) Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene, 10, 1813-1821.
2. Beerli,R.R. and Hynes,N.E. (1996) Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem., 271, 6071-6076.
3. Beerli,R.R., Wels,W. and Hynes,N.E. (1994) Intracellular expression of single-chain antibodies reverts ErbB-2 transformation. J. Biol. Chem., 269, 23931-23936.
4. Beerli,R.R., Graus-Porta,D., Woods-Cook,K., Chen,X., Yarden,Y. and Hynes,N.E. (1995) Neu differentiation activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol., 15, 6496-6505.
5. Carraway,K.L. et al. (1994) The erbB3 gene product is a receptor for heregulin. J. Biol. Chem., 269, 14303-14306.
6. Chen,X. et al. (1996) An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4. J. Biol. Chem., 271, 7620-7629.
7. Cohen,B.D., Green,J.M., Foy,L. and Fell,H.P. (1996) HER4-mediated biological and biochemical properties in NIH 3T3 cells. J. Biol. Chem., 271, 4813-4818.
8. Cohen,G.B., Ren,R. and Baltimore,D. (1995) Modular binding domains in signal transduction proteins. Cell, 80, 237-248.
9. Di Fiore,P.P., Segatto,O., Taylor,W.G., Aaronson,S.A. and Pierce,J.H. (1990) EGF receptor and erbE-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science, 248, 79-83.
10. Druker,B.J., Mamon,H.J. and Roberts,T.M. (1989) Oncogenes, growth factors, and signal transduction. New Engl. J. Med., 321, 1383-1391
11. Egan,S.E. and Weinberg,R.A. (1993) The pathway to signal achievement. Nature, 365, 781-783.
12. Fedi,P., Pierce,J.H., Di Fiore,P.P. and Kraus,M.H. (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Mol. Cell. Biol., 14, 492-500.
13. Galisteo,M.L., Dikik,I., Batzer,A.G., Langdon,W.Y. and Schlessinger,J. (1995) Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem., 270, 20242-20245.
14. Gassmann,M., Casagranda,F., Orioli,D., Simon,H., Lai,C., Klein,R. and Lemke,G. (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature, 378, 390-394.
15. Graus-Porta,D., Beerli,R.R. and Hynes,N.E. (1995) Single-chain antibody-mediated intracellular retention of ErbB-2 impairs neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol., 15, 1182-1191.
16. Gullick,W.J., Downward,D.J., Foulkes,J.G. and Waterfield,M.D. (1985) Antibodies to the ATP-binding site of the human epidermal growth factor (EGF) receptor as specific inhibitors of EGF-stimulated protein-tyrosine kinase activity. EMBO J., 4, 2869-2877.
17. Higashiyama,S., Abraham,J.A., Miller,J., Fiddes,J.C. and Klagsbrun,M. (1991) A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science, 251, 936-939.
18. Hynes,N.E. and Stern,D.F. (1994) The biology of erbB-2/neu/HER2 and its role in cancer. Biochim. Biophys. Acta, 1198, 165-184
19. Hynes,N.E., Gerber,H.A., Saurer,S. and Groner,B. (1989) Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J. Cell. Biochem., 39, 167-173
20. Jannot,Ch., Beerli,R.R., Mason,S., Gullick,W.J. and Hynes,N.E. (1996) Intracellular expression of a single-chain antibody directed to the epidermal growth factor receptor leads to growth inhibition of tumor cells. Oncogene, 13, 275-282.
21. Karunagaran,D., Tzahar,E., Liu,N., Wen,D. and Yarden,Y. (1995) Neu differentiation factor inhibits EGF binding. J. Biol. Chem., 270, 9982-9990.
22. Karunagaran,D., Tzahar,E., Beerli,R.R., Chen,X., Graus-Porta,D., Ratzkin,B.J., Seger,R., Hynes,N.E. and Yarden,Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264.
23. Kavanaugh,W.M. and Williams,L.T. (1994) An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science, 266, 1862-1865.
24. Kim,H.-H., Sierke,S.L. and Koland,J.G. (1994) Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. J. Biol. Chem., 269, 24747-24755.
25. King,C.R., Borrello,I., Bellot,F., Comoglio,P. and Schlessinger,J. (1988) EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J., 7, 1647-1651.
26. Kraus,M.H., Issing,W., Miki,T., Popescu,N.C. and Aaronson,S.A. (1989) Isolation and characterization of ERBB3, a third member of the ERBB/ epidermal growth factor receptor family: evidence for Overexpression in a subset of human mammary tumors. Proc. Natl Acad. Sci. USA, 86, 9193-9197.
27. Lax,I., Mitra,A.K., Ravera,C., Hurwitz,D.R., Rubinstein,M., Ullrich,A., Stroud,R.M. and Schlessinger,J. (1991) Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection stucture of the lignad-binding domain. J. Biol. Chem., 266, 13828-13833.
28. Lee,K.-E., Simon,H., Chen,H., Bates,B., Hung,M.-C. and Hauser,C. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature, 378, 394-398.
29. Levkovitz,G., Klapper,L.N., Tzhar,E., Freywald,A., Sela,M. and Yarden,Y. (1996) Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene, 12,1117-1125
30. Lowenstein,E.J. et al. (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell, 70, 431-442.
31. Marte,B.M., Graus-Porta,D., Jeschke,M., Fabbro,D., Hynes,N.E. and Taverna,D. (1995) NDF activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene, 10, 167-175.
32. ras. Nature, 371, 426-429.
33. Peles,E. and Yarden,Y. (1993) Neu and its ligands: from an oncogene to neural factors. BioEssays, 15, 815-824.
34. Pelicci,G. et al. (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell, 70, 93-104.
35. Pinkas-Kramarski,R. et al. (1996) Diversification of neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15, 2452-2467.
36. Plowman,G.D., Whitney,G.S., Neubauer,M.G., Green,J.M., McDonald, V.L., Todaro,G.J. and Shoyab,M. (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl Acad. Sci. USA, 87, 4905-4909.
37. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl Acad. Sci. USA, 90, 1746-1750.
38. erbB4. Nature, 366, 473-475.
39. Prigent,S.A. and Gullick,W. (1994) Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J., 13, 2831-2841.
40. Riese,D.J., van Raaij,T.M., Plowman,G.D., Andrews,G.C. and Stern,D.F. (1995) The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol., 15, 5770-5776.
41. Riese,D.J., Bermingham,Y., van Raaij,T.M., Buckley,S., Plowman,G.D. and Stern,D.F. (1996) Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-β. Oncogene, 12, 345-353.
42. Rozakis-Adcock,M. et al. (1992) Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in the activation of the Ras pathway by tyrosine kinases. Nature, 360, 689-692.
43. Salomon,D.S., Brandt,R., Ciardiello,F. and Normanno,N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19, 183-232.
44. Savage,C.R.,Jr, Inagami,T. and Cohen,S. (1972) The primary structure of epidermal growth factor. J. Biol Chem., 241, 7612-7621.
45. Shing,Y., Christofori,G., Hanahan,D., Ono,Y., Sasada,R., Igarashi,K. and Folkman,J. (1993) Betacellulin: a mitogen from pancreatic β cell tumors. Science, 259, 1604-1607.
46. Sibilia,M. and Wagner,E.F. (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science, 269, 234-238.
47. Sliwkowski,M.X. et al. (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269, 14661-14665.
48. Soltoff,S.P., Carraway,K.L., Prigent,S.A., Gullick,W.G. and Cantley,L.C. (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol., 14, 3550-3558.
49. Taverna,D., Groner,B. and Hynes,N.E. (1991) Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. Cell Growth Differentiat., 2, 145-154.
50. Threadgill,D.W. et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science, 269, 230-234.
51. Tzahar,E. et al. (1994) ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all neu differentiation/heregulin isoforma. J. Biol. Chem., 269, 25226-25233.
52. Ullrich,A. et al. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 309, 418-425.
53. van der Geer,P., Hunter,T. and Lindberg,R.A. (1994) Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol., 10, 251-337.
54. neu protein and EGF receptor modulates EGF receptor function. Cell, 61, 1339-1347.
55. Wallasch,C., Weiss,F.U., Niederfellner,G., Jallal,B., Issing,W. and Ullich,A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
56. Yamamoto,T., Ikawa,S., Akiyama,T., Semba,K., Nomura,N., Miyajima,N., Saito,T. and Toyoshima,K. (1986) Similarity of the protein encoded by the human c-erbB-2 gene to the epidermal growth factor receptor. Nature, 319, 230-234.
57. Yarden,Y. and Schlessinger,J. (1987) Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry, 26, 1443-1451.
58. Zhang,K., Sun,J., Liu,N., Wen,D., Chang,D., Thomason,A. and Yoshinaga,S.K. (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem., 271, 3884-3890.